0.8356
Biofrontera Inc Borsa (BFRI) Ultime notizie
Will Biofrontera Inc. (AI10) stock sustain bullish trend into 2025Market Growth Review & Risk Controlled Swing Alerts - Newser
Why Biofrontera Inc. (AI10) stock attracts HNW investors2025 Big Picture & Safe Entry Momentum Tips - Newser
Why Biofrontera Inc. (AI10) stock is favored by hedge fundsWeekly Trade Analysis & Daily Oversold Stock Bounce Ideas - Newser
Will Biofrontera Inc. Equity Warrant stock outperform growth indexes2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - Newser
Biofrontera completes final patient visit in Phase 1 PK study of Ameluz gel - TipRanks
Biofrontera completes phase 1 study for expanded Ameluz treatment areas - Investing.com
Biofrontera completes phase 1 study for expanded Ameluz treatment areas By Investing.com - Investing.com Canada
Last Patient Completes Biofrontera’s Phase 1 - GlobeNewswire
Can Biofrontera Inc. (AI10) stock survive global slowdownJuly 2025 Update & High Yield Stock Recommendations - Newser
Why Biofrontera Inc. stock remains on buy listsWatch List & Long Hold Capital Preservation Plans - Newser
Biofrontera Inc. (BFRI) 5.8% in After-hours: Filing for New Drug Application Boosts Stock - Stocks Telegraph
Biofrontera submits sNDA to FDA for skin cancer treatment By Investing.com - Investing.com Australia
Biofrontera Inc. (BFRI) 20.51% in After-hours: Notable Price Surge - Stocks Telegraph
Biofrontera files sNDA for Ameluz-PDT in treatment of sBCC - TipRanks
Biofrontera Inc. announces filing of supplemental new drug application - MarketScreener
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT - The Manila Times
Biofrontera Inc. Announces Filing of Supplemental New Drug - GlobeNewswire
Why global investors buy Biofrontera Inc. (AI10) stockJuly 2025 Selloffs & AI Enhanced Trading Alerts - Newser
Biofrontera (BFRI) Stock Analysis Report | Financials & Insights - Benzinga
What analysts say about Biofrontera Inc Equity Warrant stockVWAP Trading Strategies & Small Budget Trading Portfolio - earlytimes.in
PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2025 - TradingView
BIOFRONTERA REPORTS RESULTS FOR THE FIRST NINE MONTHS OF 2025 - TradingView
Biofrontera, Inc. Navigates Mixed Earnings Call - MSN
Biofrontera reports Q3 EPS (62c) vs (98c) last year - MSN
Is Biofrontera Inc. stock a top momentum playJuly 2025 Macro Moves & Growth Focused Stock Reports - BỘ NỘI VỤ
Its Stock Has Paid Off Big Time For Biofrontera Inc - Setenews
Is Biofrontera Inc a good long term investmentInsider Buying Signals & Lower Drawdowns With Smart Position Sizing - earlytimes.in
How interest rate cuts could boost Biofrontera Inc. Equity Warrant stock - BỘ NỘI VỤ
Is National Plywood Industries Limiteds Business Model Sustainable Long TermMarket Capitalization Trends & Receive Monthly Expert Trading Blueprints - earlytimes.in
How reliable is Biofrontera Inc. (AI10) stock dividend growthEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Why Biofrontera Inc. Equity Warrant is moving todayJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Biofrontera Inc. (AI10) stock could outperform next yearJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
News impact scoring models applied to Biofrontera Inc.Weekly Trade Summary & Weekly Hot Stock Watchlists - newser.com
Will Biofrontera Inc. (AI10) stock benefit from commodity supercycleGDP Growth & Safe Entry Trade Reports - newser.com
What high frequency data says about Biofrontera Inc. Equity Warrant2025 Retail Activity & Verified Entry Point Signals - newser.com
Published on: 2025-11-19 16:39:27 - newser.com
Tools to assess Biofrontera Inc. Equity Warrant’s risk profileJuly 2025 Market Mood & AI Powered Market Entry Strategies - newser.com
Will Biofrontera Inc. stock deliver long term returnsEarnings Risk Report & AI Forecast Swing Trade Picks - newser.com
Why Biofrontera Inc. stock is trending among retail tradersMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):